Navigo Proteins GmbH

General information
Navigo Proteins GmbH
Heinrich-Damerow-Straße 1
06120 Halle, Saxony-Anhalt

Contact person: Henning Afflerbach, Chief Executive Officer
Company main phone: +49 (345) 27996330
Company main fax:  +49 (345) 27996332
Year founded:2017
Source of foundation:Independent foundation
Corporate description / mission:
Navigo Proteins is a protein engineering company developing optimized affinity ligands, based on the proprietary platform of selected, small, and stable, yet highly engineerable scaffold proteins. These ligands serve as target-binding proteins in biotherapeutic molecules (precision targeting) or for commercial custom affinity purification of biologics (precision capturing®). The company is focused on developing next-generation targeted therapeutics and diagnostics, based on novel, proprietary target binding proteins called Affilin® ligands. Affilin® ligands can mimic the functional binding of antibodies, extending their use to many more applications.
State of ownership: Private / independent
Headquarters: HQ: Yes
Remarks on ownership / listings
Formerly known as Scil Proteins GmbH.
In 2017, Scil Proteins GmbH was acquired by UV-Cap GmbH & Co KG, and the new company was renamed to Navigo Proteins GmbH.
  • Biotechnology - R&D Services
  • Proteomics
  • Synthesis services
Primary therapeutic areas:
  • Neoplasms / cancer / oncology
Business model:
  • Manufacturer
  • Service company
  • Subsidiary
  • Supplier / Distributor
Customer segments:
  • Large biotech & big pharma
  • Small biotech
  • Direct (own sales force)
Summary Products / Services / Technologies
Number of Biotech Products
Technology used:
Precision Capturing® Technology: non-antibody and antibody purification.
Precision Targeting Technology: protein engineering to create proprietary Affilin® molecules.